References
Au WY, Fung A, Liu CL, Fan ST, Ma SK, Liang R et al (2006) Serial analysis of JAK2 mutation in a patient who developed essential thrombocythemia after orthotopic liver transplantation. Am J Hematol 81:880–2
Au WY, Liu CL, Lo CM, Fan ST, Ma SK (2004) Potential role for platelet apheresis for post-liver transplant thrombocytosis complicating portal vein thrombosis. J Clin Apheresis 19:192–6
Doesch C, May AE, Toncar-Pflumm G, Anders N, Geisler T, Krober S et al (2007) Acute thrombo-embolic elevated ST infarct in a patient with essential thrombocytosis. Internist (Berl) 48:1282–9
Kohl DW, Slavik KJ, Kamath G, Lehr JM, McDonald MJ, Rubio F (1998) High-dose abciximab during coronary angioplasty in a patient with essential thrombocytosis. J Invasive Cardiol 10:173–6
Michaels AD, Whisenant B, MacGregor JS (1998) Multivessel coronary thrombosis treated with abciximab (ReoPro) in a patient with essential thrombocythemia. Clin Cardiol 21:134–8
Kornblihtt LI, Cocorullo S, Miranda C, Lylyk P, Heller PG, Molinas FC (2005) Moyamoya syndrome in an adolescent with essential thrombocythemia: successful intracranial carotid stent placement. Stroke 36:E71–3
Setacci C, de Donato G, Setacci F, Chisci E, Cappelli A, Pieraccini M et al (2005) Surgical management of acute carotid thrombosis after carotid stenting: a report of three cases. J Vasc Surg 42:993–6
Zahn R, Ischinger T, Hochadel M, Mark B, Zeymer U, Jung J et al (2007) Glycoprotein IIb/IIIa antagonists during carotid artery stenting: results from the carotid artery stenting (CAS) registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Clin Res Cardiol 96:730–7
De Stefano V, Za T, Rossi E, Vannuchhi AM, Ruggeri M, Elli E, GIMEMA Chronic Myeloproliferative Neoplasms Working Party et al (2010) Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia. Am J Hematol 85:97–100
Harrison CN, Campbell PJ, Buck G, Wheatley K, East CL, Bareford D, United Kingdom Medical Research Council Primary Thrombocythemia 1 Study et al (2005) Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia. N Engl J Med 353:33–45
Informed consent
The patient and her family agree to the anonymous reporting of patient data and clinical course.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Au, WY., Law, MF., Ma, E.S.K. et al. Emergency internal carotid artery stenting with platelet glycoprotein IIbIIIa antagonist coverage in a patient with essential thrombocytosis. Ann Hematol 94, 497–499 (2015). https://doi.org/10.1007/s00277-014-2168-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-014-2168-z